Haviland Kate
Insider CIK 1663022 · AVLN Director · BPMC Chief Operating Officer, Director · FULC Director · BCAX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2026-06-30 | 2026-07-02 | 32,000 | — | $0 | 32,000 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| AVLN Avalyn Pharma Inc. | A Award deriv | 2026-04-29 | 2026-05-01 | 26,978 | — | $0 | 26,978 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 28,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 80,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 80,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 80,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,125 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 70,400 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 32,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 39,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 591 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 2 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer | 2025-07-17 | 2025-07-21 | 224,410 | — | $0 | 70,729 | SEC↗ |
| BPMC Blueprint Medicines Corp | U Tender | 2025-07-17 | 2025-07-21 | 70,729 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-07-17 | 2025-07-21 | 129,210 | — | $0 | 295,139 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2025-06-26 | 2025-06-30 | 36,000 | — | $0 | 36,000 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-04-01 | 2025-04-03 | 100 | $88.59 | $8.9K | 165,929 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-04-01 | 2025-04-03 | 1,200 | $87.34 | $104.8K | 166,029 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-04-01 | 2025-04-03 | 598 | $86.14 | $51.5K | 167,229 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-04-01 | 2025-04-03 | 600 | $85.47 | $51.3K | 167,827 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-03-05 | 2025-03-07 | 16,151 | $88.80 | $1.43M | 168,427 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2025-03-01 | 2025-03-04 | 70,400 | — | $0 | 70,400 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-03-01 | 2025-03-04 | 35,200 | — | $0 | 184,578 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-01-21 | 2025-01-23 | 1,446 | $110.24 | $159.4K | 149,378 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-11-29 | 2024-12-03 | 400 | $95.40 | $38.2K | 152,777 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-11-29 | 2024-12-03 | 1,746 | $96.74 | $168.9K | 151,031 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-11-29 | 2024-12-03 | 207 | $97.76 | $20.2K | 150,824 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2024-09-12 | 2024-09-16 | 23,746 | — | $0 | 23,746 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2024-06-17 | 2024-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-07 | 2024-03-11 | 12,464 | $90.69 | $1.13M | 153,177 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-03-01 | 2024-03-06 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-03-01 | 2024-03-06 | 40,000 | — | $0 | 165,641 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2023-06-27 | 2023-06-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 212 | $44.65 | $9.5K | 125,641 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 6,428 | $45.72 | $293.9K | 125,853 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-03-01 | 2023-03-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-03-01 | 2023-03-03 | 40,000 | — | $0 | 132,281 | SEC↗ |
| BPMC Blueprint Medicines Corp | P Buy | 2022-11-03 | 2022-11-07 | 1,100 | $43.98 | $48.4K | 92,281 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2022-06-27 | 2022-06-29 | 19,000 | — | $0 | 19,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-07 | 2022-03-08 | 1,048 | $56.18 | $58.9K | 91,181 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-03 | 2022-03-08 | 1,719 | $60.27 | $103.6K | 92,229 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2022-03-01 | 2022-03-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2022-03-01 | 2022-03-03 | 40,000 | — | $0 | 93,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-12-13 | 2021-12-15 | 1,000 | — | $0 | 591 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-12-13 | 2021-12-15 | 1,000 | $36.05 | $36.0K | 54,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-12-13 | 2021-12-15 | 285 | $99.65 | $28.4K | 54,663 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-12-13 | 2021-12-15 | 210 | $98.50 | $20.7K | 54,453 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-12-13 | 2021-12-15 | 411 | $97.60 | $40.1K | 54,042 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-12-13 | 2021-12-15 | 94 | $96.78 | $9.1K | 53,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-09-13 | 2021-09-15 | 1,000 | — | $0 | 1,591 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-09-13 | 2021-09-15 | 417 | $99.25 | $41.4K | 53,984 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-09-13 | 2021-09-15 | 261 | $99.98 | $26.1K | 54,401 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-09-13 | 2021-09-15 | 8 | $97.62 | $781 | 53,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-09-13 | 2021-09-15 | 1,000 | $36.05 | $36.0K | 54,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-09-13 | 2021-09-15 | 28 | $98.41 | $2.8K | 53,956 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-09-13 | 2021-09-15 | 286 | $101.11 | $28.9K | 54,662 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-06-28 | 2021-06-30 | 1,000 | — | $0 | 2,591 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-06-28 | 2021-06-30 | 622 | $89.91 | $55.9K | 53,972 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-06-28 | 2021-06-30 | 1,000 | $36.05 | $36.0K | 54,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-06-28 | 2021-06-30 | 24 | $89.28 | $2.1K | 53,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-06-28 | 2021-06-30 | 354 | $90.88 | $32.2K | 54,594 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2021-06-09 | 2021-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-03-15 | 2021-03-17 | 1,000 | — | $0 | 3,591 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-15 | 2021-03-17 | 322 | $104.65 | $33.7K | 53,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-15 | 2021-03-17 | 426 | $105.44 | $44.9K | 54,270 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-15 | 2021-03-17 | 108 | $106.62 | $11.5K | 54,696 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-15 | 2021-03-17 | 138 | $107.42 | $14.8K | 54,804 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-15 | 2021-03-17 | 6 | $108.16 | $649 | 54,942 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-03-15 | 2021-03-17 | 1,000 | $36.05 | $36.0K | 54,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 1,828 | $86.61 | $158.3K | 53,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 124 | $89.09 | $11.0K | 55,776 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2021-03-01 | 2021-03-03 | 26,125 | — | $0 | 26,125 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2021-03-01 | 2021-03-03 | 13,062 | — | $0 | 55,900 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-11-16 | 2020-11-18 | 409 | — | $0 | 4,591 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-11-16 | 2020-11-18 | 409 | $100.27 | $41.0K | 42,838 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-11-16 | 2020-11-18 | 409 | $36.05 | $14.7K | 43,247 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-10-16 | 2020-10-20 | 13,334 | — | $0 | 5,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-10-16 | 2020-10-20 | 3,125 | $101.56 | $317.4K | 50,038 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-10-16 | 2020-10-20 | 13,334 | $36.05 | $480.7K | 56,172 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-10-16 | 2020-10-20 | 7,200 | $100.55 | $724.0K | 42,838 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-10-16 | 2020-10-20 | 3,009 | $102.53 | $308.5K | 53,163 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-09-22 | 2020-09-24 | 3,143 | — | $0 | 2 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-09-22 | 2020-09-24 | 3,143 | $16.28 | $51.2K | 45,981 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-09-22 | 2020-09-24 | 3,143 | $85.49 | $268.7K | 42,838 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 9,285 | — | $0 | 9,285 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-03-09 | 2020-03-11 | 671 | $51.98 | $34.9K | 42,838 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-03-03 | 2020-03-03 | 4,644 | — | $0 | 3,145 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-03-03 | 2020-03-03 | 4,644 | $16.28 | $75.6K | 43,509 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2020-03-01 | 2020-03-03 | 28,500 | — | $0 | 28,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2020-03-01 | 2020-03-03 | 14,250 | — | $0 | 38,865 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-01-10 | 2020-01-14 | 7,763 | — | $0 | 7,789 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-01-10 | 2020-01-14 | 7,763 | $85.16 | $661.1K | 15,865 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-01-10 | 2020-01-14 | 7,763 | $16.28 | $126.4K | 23,628 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-08-19 | 2019-08-21 | 95 | — | $0 | 15,552 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-08-19 | 2019-08-21 | 95 | $85.00 | $8.1K | 15,865 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-08-19 | 2019-08-21 | 95 | $16.28 | $1.5K | 15,960 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2019-07-18 | 2019-07-18 | 9,285 | — | $0 | 9,285 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-07-16 | 2019-07-18 | 11,562 | — | $0 | 15,647 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-07-16 | 2019-07-18 | 11,562 | $16.28 | $188.2K | 17,436 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-07-16 | 2019-07-18 | 1,222 | $95.60 | $116.8K | 16,214 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-07-16 | 2019-07-18 | 349 | $95.03 | $33.2K | 15,865 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-06-17 | 2019-06-19 | 5,666 | — | $0 | 18,334 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-06-17 | 2019-06-19 | 6,286 | — | $0 | 27,209 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-17 | 2019-06-19 | 2,370 | $94.44 | $223.8K | 5,874 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-17 | 2019-06-19 | 2,549 | $95.53 | $243.5K | 8,244 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-17 | 2019-06-19 | 2,977 | $96.35 | $286.8K | 10,793 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-17 | 2019-06-19 | 2,123 | $97.39 | $206.8K | 13,770 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-17 | 2019-06-19 | 1,000 | $98.63 | $98.6K | 15,893 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-17 | 2019-06-19 | 933 | $100.02 | $93.3K | 16,893 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-06-17 | 2019-06-19 | 5,666 | $36.05 | $204.3K | 17,826 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-06-17 | 2019-06-19 | 6,286 | $16.28 | $102.3K | 12,160 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-03-01 | 2019-03-05 | 32,500 | — | $0 | 32,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-03-01 | 2019-03-05 | 8,750 | — | $0 | 8,750 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-03-01 | 2019-03-05 | 14,144 | — | $0 | 33,495 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-03-01 | 2019-03-05 | 7,500 | — | $0 | 24,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-03-01 | 2019-03-05 | 14,144 | $16.28 | $230.3K | 20,018 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-03-01 | 2019-03-05 | 7,500 | $36.05 | $270.4K | 27,518 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-03-01 | 2019-03-05 | 21,644 | $85.05 | $1.84M | 5,874 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2018-03-16 | 2018-03-20 | 1,571 | — | $0 | 120,639 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2018-03-16 | 2018-03-20 | 2,500 | — | $0 | 118,139 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-03-16 | 2018-03-20 | 1,200 | $100.02 | $120.0K | 6,445 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2018-03-16 | 2018-03-20 | 1,571 | $16.28 | $25.6K | 7,445 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2018-03-16 | 2018-03-20 | 2,500 | $36.05 | $90.1K | 9,945 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-03-16 | 2018-03-20 | 500 | $102.19 | $51.1K | 9,445 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-03-16 | 2018-03-20 | 1,800 | $101.32 | $182.4K | 7,645 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-03-16 | 2018-03-20 | 571 | $99.20 | $56.6K | 5,874 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2018-03-01 | 2018-03-05 | 2,800 | — | $0 | 122,210 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2018-03-01 | 2018-03-05 | 2,800 | $36.05 | $100.9K | 8,674 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-03-01 | 2018-03-05 | 2,800 | $90.00 | $252.0K | 5,874 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2018-02-27 | 2018-03-01 | 3,200 | — | $0 | 125,010 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2018-02-27 | 2018-03-01 | 3,200 | $36.05 | $115.4K | 9,074 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-27 | 2018-03-01 | 200 | $90.70 | $18.1K | 8,874 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-27 | 2018-03-01 | 200 | $89.47 | $17.9K | 8,674 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-27 | 2018-03-01 | 1,035 | $88.32 | $91.4K | 7,639 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-27 | 2018-03-01 | 1,765 | $87.70 | $154.8K | 5,874 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2018-02-16 | 2018-02-20 | 39,000 | — | $0 | 128,210 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2018-02-12 | 2018-02-14 | 6,775 | — | $0 | 89,210 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-12 | 2018-02-14 | 200 | $72.64 | $14.5K | 5,874 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2018-02-12 | 2018-02-14 | 6,775 | $16.28 | $110.3K | 12,649 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-12 | 2018-02-14 | 2,000 | $75.64 | $151.3K | 9,749 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-12 | 2018-02-14 | 2,199 | $74.58 | $164.0K | 7,550 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-12 | 2018-02-14 | 1,476 | $73.40 | $108.3K | 6,074 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-12 | 2018-02-14 | 900 | $77.19 | $69.5K | 11,749 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2017-11-21 | 2017-11-22 | 5,874 | — | $0 | 95,985 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2017-11-21 | 2017-11-22 | 5,874 | $16.28 | $95.6K | 5,874 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2017-10-05 | 2017-10-10 | 5,449 | — | $0 | 101,859 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2017-10-05 | 2017-10-10 | 5,449 | $16.28 | $88.7K | 5,449 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-10-05 | 2017-10-10 | 885 | $67.33 | $59.6K | 4,564 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-10-05 | 2017-10-10 | 3,303 | $66.58 | $219.9K | 1,261 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-10-05 | 2017-10-10 | 1,261 | $65.45 | $82.5K | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2017-09-18 | 2017-09-20 | 6,356 | — | $0 | 107,308 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-09-18 | 2017-09-20 | 6,356 | $60.03 | $381.6K | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2017-09-18 | 2017-09-20 | 6,356 | $16.28 | $103.5K | 6,356 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2017-07-05 | 2017-07-07 | 7,265 | — | $0 | 113,664 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-07-05 | 2017-07-07 | 4,313 | $55.76 | $240.5K | 2,952 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-07-05 | 2017-07-07 | 700 | $54.75 | $38.3K | 2,252 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-07-05 | 2017-07-07 | 700 | $53.58 | $37.5K | 1,552 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-07-05 | 2017-07-07 | 700 | $52.63 | $36.8K | 852 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-07-05 | 2017-07-07 | 852 | $51.54 | $43.9K | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2017-07-05 | 2017-07-07 | 7,265 | $16.28 | $118.3K | 7,265 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2017-06-28 | 2017-06-30 | 6,357 | — | $0 | 120,929 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-06-28 | 2017-06-30 | 6,357 | $50.00 | $317.9K | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2017-06-28 | 2017-06-30 | 6,357 | $16.28 | $103.5K | 6,357 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2017-03-14 | 2017-06-30 | 12,714 | — | $0 | 127,286 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-03-14 | 2017-06-30 | 12,714 | $40.01 | $508.7K | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2017-03-14 | 2017-06-30 | 12,714 | $16.28 | $207.0K | 12,714 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2017-03-14 | 2017-03-16 | 12,714 | — | $0 | 87,286 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-03-14 | 2017-03-16 | 12,714 | $40.01 | $508.7K | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2017-03-14 | 2017-03-16 | 12,714 | $16.28 | $207.0K | 12,714 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2017-02-16 | 2017-02-21 | 40,000 | — | $0 | 140,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2016-02-01 | 2016-02-02 | 100,000 | — | $0 | 100,000 | SEC↗ |